Invesaro

Stocks APGE Earnings

Earnings

Apogee Therapeutics, Inc. (APGE) earnings

Quarterly results of Apogee Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when APGE files with the SEC.

Next earnings date

Apogee Therapeutics, Inc. is expected to report around December 25, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Apogee Therapeutics, Inc. reported revenue of - and a net loss of $85.9M.

Diluted earnings per share were -$1.14.

Filed with the SEC on August 10, 2026.

Net income by quarter
Q3 24: -$49M -$49M Q3 24Q4 24: -$67.2M -$67.2M Q4 24Q1 25: -$55.3M -$55.3M Q1 25Q2 25: -$66.1M -$66.1M Q2 25Q3 25: -$65M -$65M Q3 25Q4 25: -$69.4M -$69.4M Q4 25Q1 26: -$74.1M -$74.1M Q1 26Q2 26: -$85.9M -$85.9M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026---$85.9M-$1.14
Q1 FY2026March 31, 2026---$74.1M-$1.06
Q4 FY2025December 31, 2025---$69.4M-
Q3 FY2025September 30, 2025---$65M-$1.11
Q2 FY2025June 30, 2025---$66.1M-$1.13
Q1 FY2025March 31, 2025---$55.3M-$0.95
Q4 FY2024December 31, 2024---$67.2M-
Q3 FY2024September 30, 2024---$49M-$0.86

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Apogee Therapeutics, Inc.'s next earnings date?

Apogee Therapeutics, Inc. is expected to report around December 25, 2026. That is an estimate from its filing rhythm (the usual gap between its reports), not a date the company has announced.

Get an email when APGE reports

Follow APGE and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when APGE files with the SEC.

Source: quarterly figures Apogee Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Apogee Therapeutics, Inc.